You just read:

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

News provided by

Sci-Engi-Medco Solutions Inc.

Jan 12, 2018, 21:30 ET